PEPSE Audit
| Percentage of patients with (%) | 2014–2015 | 2016 | BHIVA guidance recommendation (2011/2015) | ||
|---|---|---|---|---|---|
| Baseline HIV test | 81 | 90 | 100 | ||
| Prescriptions that fit recommended indications | 55 | 71 | 90 | ||
| Prescriptions administered within 72 hours of exposure | 83 | 100 | 90 | ||
| Prescriptions within 24 hours of exposure | 36 | 44 | 90 | ||
| Completion of 4-week course of PEPSE | 47 | 49 completed, | 19 ongoing, | 32 unknown or incomplete | 75 |
| STI screen | 51 | 80 | 90 |